24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
PEPTIDOMIMETIC CD40L BINDING |
38.54% |
|
CANCER |
32.29% |
|
ENZYME DYNAMICS |
21.88% |
|
ALZHEIMERS |
7.29% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
35.98% |
|
CANCER |
33.71% |
|
PEPTIDOMIMETIC CD40L BINDING |
22.35% |
|
ENZYME DYNAMICS |
7.95% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
41.18% |
|
ENZYME DYNAMICS |
26.13% |
|
ALZHEIMERS |
22.09% |
|
CANCER |
6.57% |
|
PEPTIDOMIMETIC CD40L BINDING |
4.04% |